Health Care & Life Sciences » Biotechnology | Neptune Technologies & Bioressources Inc.

Neptune Technologies & Bioressources Inc. | Ownership

Companies that own Neptune Technologies & Bioressources Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Perceptive Advisors LLC
8,574,015
10.82%
200,000
0.79%
08/06/2018
Schottenfeld Qualified Associates LP
3,574,655
4.51%
-112,885
38.21%
06/25/2018
Horizons ETFs Management (Canada), Inc.
2,254,809
2.85%
12,898
0.71%
07/31/2018
O'Shaughnessy Asset Management LLC
751,128
0.95%
0
0.05%
06/30/2018
Susquehanna Financial Group LLLP
470,568
0.59%
402,245
0.01%
06/30/2018
DWS Investment GmbH
269,035
0.34%
228,100
0%
06/30/2018
Desjardins Global Asset Management, Inc.
125,683
0.16%
125,683
0.01%
04/30/2018
Spark Investment Management LLC
117,000
0.15%
-11,000
0.03%
06/30/2018
Group One Trading LP
86,816
0.11%
5,246
0.03%
06/30/2018
Alpine Global Management LLC
85,000
0.11%
-99,993
0.19%
06/30/2018

About Neptune Technologies & Bioressources

View Profile
Address
545, Promenade du Centropolis
Laval Québec H7T 0A3
Canada
Employees -
Website http://www.neptunecorp.com
Updated 07/08/2019
Neptune Technologies & Bioresources, Inc. engages in the development and commercialization specialty ingredients. It offers the MaxSimil a patented ingredient that may enhance the absorption of lipid-based nutraceuticals, and a variety of other marine and seed oils. It operates through the Nutraceutical, Cannabis, and Cardiovascular segments.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.